JGECX
Price
$13.25
Change
-$0.15 (-1.12%)
Updated
Nov 13 closing price
Net Assets
723.34M
TEDSX
Price
$32.44
Change
-$0.36 (-1.10%)
Updated
Nov 13 closing price
Net Assets
9.43B
Interact to see
Advertisement

JGECX vs TEDSX

Header iconJGECX vs TEDSX Comparison
Open Charts JGECX vs TEDSXBanner chart's image
JHancock Global Equity C
Price$13.25
Change-$0.15 (-1.12%)
VolumeN/A
Net Assets723.34M
Franklin Mutual Global Discovery C
Price$32.44
Change-$0.36 (-1.10%)
VolumeN/A
Net Assets9.43B
JGECX vs TEDSX Comparison Chart in %
View a ticker or compare two or three
VS
JGECX vs. TEDSX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGECX is a Hold and TEDSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TEDSX has more cash in the bank: 9.43B vs. JGECX (723M). TEDSX pays higher dividends than JGECX: TEDSX (0.75) vs JGECX (0.20). JGECX was incepted earlier than TEDSX: JGECX (11 years) vs TEDSX (33 years). JGECX (2.01) and TEDSX (1.96) have similar cost to investors . JGECX (36.00) and TEDSX (34.55) have comparable annual turnover. JGECX (1000) and TEDSX (1000) have matching initial minimum investment requirements. TEDSX annual gain was more profitable for investors over the last year : 5.08 vs. JGECX (-2.07). TEDSX return over 5 years is better than : 27.14 vs. JGECX (5.92).
JGECXTEDSXJGECX / TEDSX
Total Expense Ratio2.001.96102%
Annual Report Gross Expense Ratio2.011.96103%
Fund Existence11 years33 years-
Gain YTD13.73416.85182%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets723M9.43B8%
Annual Yield % from dividends0.200.7526%
Returns for 1 year-2.075.08-41%
Returns for 3 years20.5317.27119%
Returns for 5 years5.9227.1422%
Returns for 10 years32.1710.70301%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACBU10.41N/A
N/A
Artius II Acquisition Inc
MSDL16.72-0.04
-0.24%
Morgan Stanley Direct Lending Fund
KOSS4.80-0.12
-2.44%
Koss Corp
CTNM10.90-0.57
-4.97%
Contineum Therapeutics
GTLB43.97-2.48
-5.34%
GitLab